Aridis Pharmaceuticals Q3 EPS $(0.87) Up From $(1.97) YoY

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.87) per share. This is a 55.84 percent increase over losses of $(1.97) per share from the same period last year.

Benzinga · 11/13/2019 21:18

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(0.87) per share. This is a 55.84 percent increase over losses of $(1.97) per share from the same period last year.